GLP-1 Beyond the Circuit: What Functional Systems Theory Adds to the Biology of Eating
Acknowledgment and Question
I would like to begin by thanking Robert Sapolsky. I have followed the science and clinical application of GLP-1 receptor agonists for a long time: their effects on appetite, satiety, body weight, gastric emptying, food preference, reward, and perhaps forms of craving that extend beyond food. Yet it was only after watching Sapolsky’s discussion of Ozempic that a question I had not previously formulated clearly came into focus.
His explanation is compelling precisely because it is lucid. It begins with the logic of regulation: hunger-promoting and satiety-related signals, hypothalamic circuitry, reward-related processes, appetite, food seeking, and feedback. GLP-1 receptor agonists enter this organization and alter the conditions under which hunger, satiety, reward, and eating are regulated. Sapolsky then moves beyond a narrowly metabolic account, discussing the possibility that GLP-1-related effects extend into food reward, craving, and potentially other reward-driven behavior.
This is not a simplistic explanation. Nor is it wrong. GLP-1 receptor agonists do act through gastrointestinal, metabolic, neural, and central appetite-regulation mechanisms. Current research describes effects on gastric emptying, satiety, hypothalamic regulation, food seeking, and reward-related neural processing.
But while listening, another question emerged:
What does the regulatory-circuit account explain fully, and what remains unexplained when the subject is not merely appetite, but human eating?
If eating were only an output of hunger and satiety circuits, then a circuit-based explanation might be sufficient. But human eating is not one uniform act. The same movement toward food may restore energy, seek sensory pleasure, relieve anxiety, interrupt boredom, maintain social belonging, avoid an intolerable emotion, create a feeling of safety or control, or express an automatic learned routine that has begun before conscious thought has caught up.
The question, therefore, is not whether the feedback-loop and regulatory-circuit model is correct. It is. The question is whether it is complete at the level of whole-organism action.
Functional Systems Theory may add something at exactly this point. It does not deny hormonal signaling, neural circuits, or feedback. It asks a different question: what adaptive result is the organism currently organized to achieve, and how do bodily, neural, learned, contextual, automatic, and conscious processes become assembled around that result?
This article is an exploration of that question.
What the Circuit Model Explains
The modern GLP-1 story is a major achievement of integrative physiology. It has helped displace the moralizing idea that appetite, eating, and body weight are simply expressions of weak will or poor character.
GLP-1 is a gut-derived peptide with multiple metabolic and neurobehavioral effects. GLP-1 receptor agonists can delay gastric emptying, promote satiation, reduce appetite, and influence central pathways involved in food intake. Research also suggests that GLP-1-related signaling intersects with reward-relevant neural processes, although the precise mechanisms, their relative importance in humans, and their clinical implications remain under active study.
The regulatory logic can be represented simply:
This model is indispensable. It explains why eating cannot be reduced to a consciously chosen act. Hunger is not a proposition. Satiety is not a moral achievement. Reward salience is not merely a failure of rational thought. The body participates in every eating decision before, during, and after conscious deliberation.
The circuit model also improves on an older and narrower view in which eating is governed by a single “hunger center” or a simple caloric set point. Contemporary accounts recognize interacting processes: visceral signals, gastric filling, energy balance, sensory cues, learned associations, food palatability, reward anticipation, stress, social context, and executive control.
Yet the model usually retains a characteristic structure. It seeks to identify:
The signal.
The receptor.
The neural pathway.
The behavioral effect.
The regulatory consequence.
This is the language of mechanism. It asks how the organism regulates intake.
That question is necessary. But it is not identical to another question:
What is food-related action accomplishing for this organism, in this person, in this situation, at this moment?
A hormone or circuit may influence the probability of eating. It does not by itself identify the result that makes eating meaningful within a particular organization of life.
From Regulatory Loop to Functional System
The difference between a regulatory loop and a functional system is not that one contains feedback and the other does not. Feedback is essential to both.
A basic feedback-loop account may be expressed as:
This is the logic of homeostatic regulation. A physiological change is detected; compensatory mechanisms are recruited; the system moves toward a viable range.
Functional Systems Theory, associated especially with Pyotr Anokhin, asks how an organism becomes organized around an anticipated useful result. In this account, action is not merely a response to a deviation. It is a temporary, integrated organization of processes directed toward achieving and evaluating a result.
In simplified form:
The central element is not movement, appetite, secretion, or even feedback alone. It is the relationship between the anticipated result and the achieved result.
A regulatory loop may explain why an appetite-related signal becomes weaker. A functional-systems account asks:
What result was the person seeking through food?
What result did the organism anticipate from eating?
Was the anticipated result energy restoration, pleasure, relief, safety, distraction, social participation, or control?
Did eating actually produce that result?
What did the system learn from the outcome?
How will that learning change the probability and organization of the next action?
This is not a rejection of neuroendocrinology. It is a shift in explanatory level.
The circuit model tells us that GLP-1 signaling may alter hunger, food reward, satiation, or craving. Functional Systems Theory asks how those altered conditions change the organization of food-related action within the life of a whole person.
The relationship between the two models is therefore not competitive:
Regulatory loops are among the mechanisms through which functional systems operate. Functional systems describe the changing organization of mechanisms around an adaptive result.
A person does not work either by circuits or by functional systems. The person works through circuits, hormonal signals, learned patterns, bodily states, social conditions, and conscious interpretation—all of which may be assembled differently depending on what result has become functionally dominant.
Eating Is Not One Functional System
The word eating may conceal several different functional organizations.
Food may be sought because the organism requires energy. In that case, the relevant result may be restoration of metabolic adequacy or relief of hunger. GLP-1-related satiety signaling has an obvious role within this organization.
But food may also be sought when physiological hunger is modest or absent. The anticipated result may be:
Sensory pleasure.
Relief from tension.
Interruption of loneliness or boredom.
Escape from distressing thought.
A predictable reward after effort.
A feeling of control.
Social connection.
Compliance with a family, cultural, or occupational rhythm.
Completion of a familiar evening routine.
These possibilities should not be confused with a claim that all eating outside energy need is pathological. Eating is inherently social, cultural, sensory, emotional, and symbolic. The point is more limited: the same visible act may belong to different functional systems, and its meaning cannot be inferred from the act alone.
The question is not simply, “Why did this person eat?” It is:
What result did this action system treat as sufficient or successful?
This question can be made clinically and practically usable through three nodes:
This framework is adapted from the functional-systems account of habit developed in Habit as a Functional System. There, a habit is understood not as a bare repeated behavior, but as a recurrent organization around a result, an internal model, and an action–feedback–learning sequence.
Consider two people who eat the same dessert at 10 p.m.
One has eaten little during a difficult day and is physiologically hungry. The result sought may be nourishment and restoration. Another has eaten adequately but has just experienced conflict, loneliness, or professional humiliation. The result may be rapid reduction of tension or temporary withdrawal from painful experience.
The visible behavior is identical. The circuits involved may partly overlap. But the functional systems are not identical.
This distinction matters for GLP-1 therapy. A drug may reduce hunger and dampen food salience. It may make one habitual route toward relief less compelling or less easily launched. But it does not necessarily redefine the broader result the person is seeking. If the reference point remains, “I need immediate relief,” the system may still seek another available route toward that result.
This is not an argument that GLP-1 therapy merely “substitutes” one behavior for another. Such an outcome cannot be assumed. It is a functional hypothesis: reducing the accessibility or reward value of food-related action may alter one component of a wider organization, while the underlying need, learned model, and short-loop orientation may remain unchanged, weaken, or become reorganized in different ways across individuals.
Consciousness Within Automatism
This is where Functional Systems Theory may make its most useful addition.
Public discussion of GLP-1 drugs often oscillates between two inadequate pictures. One says that eating is a matter of willpower. The other says that eating is a matter of biology, meaning hormones and neural circuits. The first moralizes. The second may correct the moralization but risk removing the person as an active, learning organism.
The alternative is not to restore a simplistic doctrine of conscious control. Most eating-related behavior is not preceded by a fully articulated decision. Learned cues, time of day, stress, fatigue, sensory exposure, social rituals, and internal bodily states can activate food-seeking rapidly and with little reflective participation.
But automatic does not mean purposeless. Nor does it mean that consciousness is absent from the entire system.
In the functional-systems account of habit, consciousness and automatism are not opposites. They are interacting modes of organization. Automatism carries recurrent, economical, well-learned portions of action. Consciousness can enter at selected points: in recognizing the result being sought, interpreting the situation, authorizing or interrupting an action, evaluating mismatch, and revising what is learned from the outcome. A simplified short-loop pattern may look like this:
GLP-1 therapy may alter this sequence by reducing hunger, decreasing food-related reward, increasing satiation, or changing the intensity of craving. The automatic sequence may become less urgent or less compelling.
That altered biological field may create an opportunity. A person may be more able to notice the cue, identify the actual result sought, tolerate a feeling without immediate action, test an alternative response, and learn a different relation between discomfort and behavior.
But this possibility must be expressed carefully. It is not a claim that medication automatically produces psychological insight, nor that every patient requires a psychotherapeutic explanation for eating. It is a proposal that medication, learning, environment, relationships, and conscious participation can interact.
The practical question becomes:
Where, in this person’s food-related functional system, does conscious participation remain possible—and how might the altered biological conditions support a more flexible organization?
That question is neither moralistic nor anti-pharmacological. It is a question of integration.
What Functional Systems Theory Contributes
The most important contribution of Functional Systems Theory is not to replace current GLP-1 science. It is to make visible several questions that a purely circuit-centered explanation may leave in the background.
First, it distinguishes reduced intake from reorganized action. Less eating may be an important clinical outcome. But it does not automatically reveal whether the person’s broader capacity for flexibility, self-care, social participation, symptom relief, or adaptive coping has changed.
Second, it distinguishes the visible behavior from the result served by that behavior. Food seeking cannot be understood solely by counting episodes or measuring calories. The same behavior can perform different functions in different contexts.
Third, it places automaticity within a developmental history. A habitual food-related action is not simply an error in a circuit. It may be a condensed product of repeated action–feedback–learning cycles. What was initially a conscious experiment in comfort, reward, or relief can become a rapidly activated routine.
Fourth, it provides a non-moralistic role for consciousness. Consciousness does not have to supervise every urge or defeat every biological signal. It may participate at critical points: revising the reference point, recognizing the internal model, testing alternative action, and interpreting feedback differently.
Finally, it directs attention to the outcome that matters most:
Does the reorganized system widen or narrow the person’s capacity to live?
This question is broader than weight change, though it does not oppose weight reduction where that reduction improves health, comfort, mobility, metabolic status, or quality of life. It asks whether treatment helps the person achieve a more flexible and life-supporting organization of eating, activity, rest, relationships, and self-regulation.
Conclusion
Sapolsky’s discussion of Ozempic makes the biological logic of GLP-1 unusually clear: signals of hunger, satiety, and reward are not abstractions; they are embodied processes with real behavioral consequences. His explanation deserves appreciation because it makes the regulatory-circuit model visible in a form that invites deeper questions.
Functional Systems Theory does not challenge the reality of GLP-1 signaling, gut–brain communication, hypothalamic regulation, reward circuitry, or feedback. It asks what these mechanisms are participating in when a living person acts.
Eating is not merely the endpoint of a hormonal signal. It is often a complex functional organization of need, prediction, learned history, bodily state, context, anticipated result, action, feedback, and revision. Some of that organization is automatic. Some can become conscious. None of it is adequately understood by invoking either willpower or biology alone.
The organism therefore does not function either through regulatory loops or through functional systems. Regulatory loops are among the mechanisms that functional systems recruit. The larger task is to understand how those mechanisms become organized around results: sometimes energy restoration, sometimes pleasure, sometimes relief, sometimes connection, and sometimes patterns that once served a purpose but no longer support the wider life of the person.
GLP-1 therapy may alter the biological conditions under which food-related systems are assembled. The next question is whether that altered field can also support new learning, more flexible action, revised internal models, and outcomes that the person recognizes not only as lighter, but as more livable.
You can learn more by reading our e-book
Comments
Post a Comment